Silicon Labs Reports First Quarter 2025 Results

Wireless IoT leader delivers strong sequential and year-over-year revenue growth

AUSTIN, Texas, May 13, 2025 /PRNewswire/ -- Silicon Labs (NASDAQ: SLAB), the leading innovator in low-power wireless, reported financial results for the first quarter, which ended April 5, 2025.

"Silicon Labs drove strong sequential and year-over-year revenue growth as design wins across multiple end markets continued ramping in the first quarter of 2025," said Matt Johnson, President and Chief Executive Officer at Silicon Labs. "Despite macroeconomic uncertainty and shifting trade dynamics, we remain confident in Silicon Labs' ability to outperform the market given our leadership position in secular high-growth applications and consistent share gains."

First Quarter Financial Highlights

    --  Revenue was $178 million
    --  Industrial & Commercial revenue for the quarter was $96 million, up 47%
        year-over-year
    --  Home & Life revenue for the quarter was $82 million, up 99%
        year-over-year

Results on a GAAP basis:

    --  GAAP gross margin was 55.0%
    --  GAAP operating expenses were $130 million
    --  GAAP operating loss was $32 million
    --  GAAP diluted loss per share was $(0.94)

Results on a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, and certain other items as set forth in the below GAAP to Non-GAAP reconciliation tables were as follows:

    --  Non-GAAP gross margin was 55.4%
    --  Non-GAAP operating expenses were $105 million
    --  Non-GAAP operating loss was $7 million
    --  Non-GAAP diluted loss per share was $(0.08)

Business Highlights

    --  Silicon Labs' first device in its next-generation Series 3 platform on
        22nm process technology is now ramping into production. The Series 3
        platform will be complementary to Series 2, with advancements in
        performance, capabilities, and features, including higher levels of
        compute and AI inference, as well as scalable memory architectures and
        backwards code compatibility with Series 2.


    --  Announced its new Series 2 BG29 family of Bluetooth Low Energy (LE)
        SoCs, designed to bring higher levels of compute and connectivity in
        ultra-compact form factor without compromising wireless performance. The
        BG29 family is ideal for today's most intensive Bluetooth LE
        applications like wearable medical devices, asset trackers, and smart
        sensors.


    --  Introduced the BG22L and BG24L SoCs for Bluetooth(® )LE optimized for
        common Bluetooth applications like asset tracking tags and small
        appliances. The BG22L brings the most competitive combination of
        security, processing power, and connectivity for high-volume, low-power
        applications. The BG24L SoC also includes the Silicon Labs accelerator
        for AI/ML applications and support for the latest in Bluetooth Channel
        Sounding in radio congested areas like warehouses, smart cities, and
        large residential apartment complexes.
    --  Announced that its MG26 family of wireless SoCs is now generally
        available through Silicon Labs and its distribution partners. As the
        industry's most advanced, high-performance Matter and concurrent
        multi-protocol solution to date, the MG26 SoC features double the Flash
        and RAM of other Silicon Labs multi-protocol devices, advanced AI/ML
        processing, and best-in-class security to empower developers to design
        future-proof Matter applications.

Business Outlook

The company expects second-quarter revenue to be between $185 to $200 million. The company also estimates the following results:

On a GAAP basis:

    --  GAAP gross margin to be between 55% to 57%
    --  GAAP operating expenses of approximately $129 million to $131 million
    --  GAAP diluted loss per share between $(0.55) to $(0.95)

On a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, and certain other items as set forth in the reconciliation tables:

    --  Non-GAAP gross margin to be between 55% to 57%
    --  Non-GAAP operating expenses of approximately $106 million to $108
        million
    --  Non-GAAP diluted earnings (loss) per share between $(0.01) to $0.19

Earnings Webcast and Conference Call

Silicon Labs will host an earnings conference call to discuss the quarterly results and answer questions at 7:30 am CDT today. An audio webcast will be available on Silicon Labs' website (www.silabs.com) under Investor Relations. In addition, the company will post an audio recording of the event at investor.silabs.com and make a replay available through June 12, 2025.

About Silicon Labs

Silicon Labs (NASDAQ: SLAB) is the leading innovator in low-power wireless connectivity, building embedded technology that connects devices and improves lives. Merging cutting-edge technology into the world's most highly integrated SoCs, Silicon Labs provides device makers the solutions, support, and ecosystems needed to create advanced edge connectivity applications. Headquartered in Austin, Texas, Silicon Labs has operations in over 16 countries and is the trusted partner for innovative solutions in the smart home, industrial IoT, and smart cities markets. Learn more at silabs.com

Forward-Looking Statements

This press release contains forward-looking statements based on Silicon Labs' current expectations. The words "believe", "estimate", "expect", "intend", "anticipate", "plan", "project", "will", and similar phrases as they relate to Silicon Labs are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Silicon Labs and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: fluctuating changes in global trade policies, including the imposition of tariffs, duties, trade sanctions, or other barriers to international commerce; the competitive and cyclical nature of the semiconductor industry; the challenging macroeconomic environment, including disruptions in the financial services industry; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Labs' business and results of operations to risks of natural disasters, epidemics or pandemics, war and political unrest; risks that demand and the supply chain may be adversely affected by military conflict (including in the Middle East, and between Russia and Ukraine), terrorism, sanctions or other geopolitical events globally (including in the Middle East, and conflict between Taiwan and China); risks that Silicon Labs may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; risks associated with international activities (including trade barriers, particularly with respect to China); intellectual property litigation risks; risks associated with acquisitions and divestitures; product liability risks; difficulties managing and/or obtaining sufficient supply from Silicon Labs' distributors, manufacturers and subcontractors; dependence on a limited number of products; absence of long-term commitments from customers; inventory-related risks; difficulties managing international activities; risks that Silicon Labs may not be able to manage strains associated with its growth; credit risks associated with its accounts receivable; dependence on key personnel; stock price volatility; the impact of COVID-19 on the U.S. and global economy; debt-related risks; capital-raising risks; the timing and scope of share repurchases and/or dividends; average selling prices of products may decrease significantly and rapidly; information technology risks; cyber-attacks against Silicon Labs' products and its networks; risks associated with any material weakness in our internal controls over financial reporting; and other factors that are detailed in the SEC filings of Silicon Laboratories Inc. Silicon Labs disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. References in this press release to Silicon Labs shall mean Silicon Laboratories Inc.

Note to editors: Silicon Laboratories, Silicon Labs, the "S" symbol, and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.


                                        
            
              Silicon Laboratories Inc.


                             
            
              Condensed Consolidated Statements of Operations


                                  
            
              (In thousands, except per share data)


                                               
            
              (Unaudited)




                                                                                                           Three Months Ended


                                                                                                  April 5,                    March 30,
                                                                                                      2025                          2024



     Revenues                                                                                    $177,714                      $106,375



     Cost of revenues                                                                              79,937                        51,306



     Gross profit                                                                                  97,777                        55,069



     Operating expenses:



     Research and development                                                                      88,219                        80,650



     Selling, general and administrative                                                           41,638                        33,553



     Operating expenses                                                                           129,857                       114,203



     Operating loss                                                                              (32,080)                     (59,134)



     Other income (expense):



     Interest income and other, net                                                                 3,793                         2,732



     Interest expense                                                                               (284)                        (509)



     Loss before income taxes                                                                    (28,571)                     (56,911)



     Provision (benefit) for income taxes                                                           1,899                         (385)



     Net loss                                                                                   $(30,470)                    $(56,526)





     Loss per share:



     Basic                                                                                        $(0.94)                      $(1.77)



     Diluted                                                                                      $(0.94)                      $(1.77)





     Weighted-average common shares outstanding:



     Basic                                                                                         32,465                        31,910



     Diluted                                                                                       32,465                        31,910

Non-GAAP Financial Measurements

In addition to the GAAP results provided throughout this document, Silicon Labs has provided non-GAAP financial measurements on a basis excluding non-cash and other charges and benefits. Details of these excluded items are presented in the tables below, which reconcile the GAAP results to non-GAAP financial measurements.

The non-GAAP financial measurements do not replace the presentation of Silicon Labs' GAAP financial results. These measurements provide supplemental information to assist management and investors in analyzing Silicon Labs' financial position and results of operations. Silicon Labs has chosen to provide this information to investors to enable them to perform meaningful comparisons of past, present and future operating results and as a means to emphasize the results of core on-going operations.


                                                   
     
               Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures


                                                       
             
                (In thousands, except per share data)




                                                                                                                             
        
               Three Months Ended

                                                                                                                                
       
                April 5, 2025



     
                Non-GAAP Income Statement Items          GAAP                                    GAAP                                Stock                             Intangible    Non-GAAP     Non-GAAP
                                                                                                                                                                   Asset
                                                          Measure                                Percent of                         Compensation                                        Measure     Percent of
                                                                                                                                                                         Amortization
                                                                                                   Revenue                             Expense                                                        Revenue



     Revenues                                           $177,714





     Gross profit                                         97,777                                     55.0 %                                 $613                
         $              -    $98,390         55.4 %





     Research and development                             88,219                                     49.6 %                               12,007                                 5,437      70,775         39.8 %





     Selling, general and administrative                  41,638                                     23.4 %                                7,094                                           34,544         19.4 %





     Operating expenses                                  129,857                                     73.1 %                               19,101                                 5,437     105,319         59.3 %





     Operating income (loss)                            (32,080)                                  (18.1 %)                               19,714                                 5,437     (6,929)       (3.9 %)


                                                               
       
       Three Months Ended

                                                                 
       
       April 5, 2025


                   Non-GAAP Loss Per Share     GAAP      Stock                     Intangible      Income       Non-

                                             Measure Compensation                    Asset          Tax         GAAP

                                                       Expense*                  Amortization*  Adjustments   Measure



     Net income (loss)                    $(30,470)      $19,714                        $5,437        $2,583   $(2,736)





     Diluted shares outstanding              32,465                                                            32,465





     Diluted loss per share                 $(0.94)                                                          $(0.08)




              *   Represents pre-tax amounts


                        
              
        Unaudited Forward-Looking Statements Regarding Business Outlook


                                      
      
                (In millions, except per share data)




                                                                                             
              
         Three Months Ended
                                                                                                      
         July 5, 2025



     
                Business Outlook                                                   GAAP                             Non-GAAP               Non-GAAP

                                                                                    Measure                         Adjustments**             Measure



     Gross margin                                                               55% to 57%                                  - %          55% to 57%





     Operating expenses                                            
              $129 to $131                                 $(23)   
         $106 to $108





     Diluted earnings (loss) per share                       
              $(0.55) to $(0.95)               
            $0.74 to $0.94 
       $(0.01) to $0.19



     ** Non-GAAP adjustments include the following estimates: stock compensation expense of $20.5 million, intangible asset amortization of $3.3 million, and the
         application of a long-term non-GAAP tax rate of 20%.


                                                                                  
              
           Silicon Laboratories Inc.


                                                                            
              
           Condensed Consolidated Balance Sheets


                                                                            
              
           (In thousands, except per share data)


                                                                                         
         
                (Unaudited)




                                                                                                                                       April 5, December 28,
                                                                                                                                           2025          2024


                                                                                           
         
                Assets



           Current assets:



             Cash and cash equivalents                                                                                                $324,877      $281,607



             Short-term investments                                                                                                     99,928       100,554



             Accounts receivable, net                                                                                                   52,066        54,479



             Inventories                                                                                                                83,397       105,639



             Prepaid expenses and other current assets                                                                                  58,402        59,754



           Total current assets                                                                                                        618,670       602,033



           Property and equipment, net                                                                                                 129,707       132,136



           Goodwill                                                                                                                    376,389       376,389



           Other intangible assets, net                                                                                                 31,062        36,499



           Other assets, net                                                                                                            73,668        75,617



           Total assets                                                                                                             $1,229,496    $1,222,674


                                                                            
              
           Liabilities and Stockholders' Equity



           Current liabilities:



             Accounts payable                                                                                                          $53,819       $42,448



             Deferred revenue and returns liability                                                                                      6,478         3,073



             Other current liabilities                                                                                                  59,422        52,362



           Total current liabilities                                                                                                   119,719        97,883



           Other non-current liabilities                                                                                                41,358        44,770



           Total liabilities                                                                                                           161,077       142,653



           Commitments and contingencies



           Stockholders' equity:



             Preferred stock - $0.0001 par value; 10,000 shares authorized; no shares issued                                                 -



             Common stock - $0.0001 par value; 250,000 shares authorized; 32,473 and 32,458                                                  3             3
      shares issued and outstanding at April 5, 2025 and December 28, 2024, respectively



             Additional paid-in capital                                                                                                 96,838        78,227



             Retained earnings                                                                                                         971,251     1,001,721



             Accumulated other comprehensive income                                                                                        327            70



           Total stockholders' equity                                                                                                1,068,419     1,080,021



           Total liabilities and stockholders' equity                                                                               $1,229,496    $1,222,674


                                                                            
              
                Silicon Laboratories Inc.


                                                                 
              
                Condensed Consolidated Statements of Cash Flows


                                                                                 
              
                (In thousands)


                                                                                   
              
                (Unaudited)




                                                                                                                                                   Three Months Ended


                                                                                                                                          April 5,                    March 30,
                                                                                                                                              2025                          2024



     
                Operating Activities



     Net loss                                                                                                                           $(30,470)                    $(56,526)



     Adjustments to reconcile net loss to net cash provided by (used in) operating activities:



     Depreciation of property and equipment                                                                                                 6,248                         6,634



     Amortization of other intangible assets                                                                                                5,437                         6,079



     Stock-based compensation expense                                                                                                      19,714                        13,612



     Deferred income taxes                                                                                                                (1,514)                      (5,270)



     Changes in operating assets and liabilities:



     Accounts receivable                                                                                                                    2,412                       (3,321)



     Inventories                                                                                                                           22,098                       (3,958)



     Prepaid expenses and other assets                                                                                                      2,973                      (15,466)



     Accounts payable                                                                                                                       9,234                      (13,829)



     Other current liabilities and income taxes                                                                                            11,870                         1,554



     Deferred revenue and returns liability                                                                                                 3,405                         1,804



     Other non-current liabilities                                                                                                        (3,279)                      (3,113)



     Net cash provided by (used in) operating activities                                                                                   48,128                      (71,800)





     
                Investing Activities



     Purchases of marketable securities                                                                                                  (19,728)                      (9,794)



     Sales of marketable securities                                                                                                        10,005                        25,763



     Maturities of marketable securities                                                                                                   10,675                        55,188



     Purchases of property and equipment                                                                                                  (4,852)                      (2,047)



     Proceeds from sale of equity investment                                                                                                    -                       12,382



     Net cash provided by (used in) investing activities                                                                                  (3,900)                       81,492





     
                Financing Activities



     Payments on debt                                                                                                                           -                     (45,000)



     Payment of taxes withheld for vested stock awards                                                                                      (958)                      (1,048)



     Proceeds from the issuance of common stock                                                                                                 -                          341



     Net cash used in financing activities                                                                                                  (958)                     (45,707)





     Increase (decrease) in cash and cash equivalents                                                                                      43,270                      (36,015)



     Cash and cash equivalents at beginning of period                                                                                     281,607                       227,504



     Cash and cash equivalents at end of period                                                                                          $324,877                      $191,489

View original content to download multimedia:https://www.prnewswire.com/news-releases/silicon-labs-reports-first-quarter-2025-results-302453390.html

SOURCE Silicon Labs